search
Back to results

Study to Evaluate Safety & Effectiveness of Spinal Sealant

Primary Purpose

Cerebrospinal Fluid Leakage, Subdural

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Spinal Sealant
Standard of Care
Sponsored by
Integra LifeSciences Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cerebrospinal Fluid Leakage, Subdural focused on measuring Prevention of CSF leak

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subjects scheduled for a spinal procedure that requires a dural incision

Sites / Locations

  • Confluent Surgical, Inc.

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Spinal Sealant System

Standard of Care

Arm Description

Spinal Sealant System

Standard of care methods as an adjunct to sutured dural repair

Outcomes

Primary Outcome Measures

Percent(%) Success in Obtaining a Watertight Closure Following Assigned Treatment (Spinal Sealant or Control)
Percent(%) success in obtaining a watertight closure following assigned treatment (Spinal Sealant or Control) where success is defined as: A watertight closure of the dural repair intraoperatively after study treatment, confirmed by Valsalva maneuver at 20-25 cm H2O for 5-10 seconds.

Secondary Outcome Measures

Full Information

First Posted
March 6, 2007
Last Updated
August 7, 2017
Sponsor
Integra LifeSciences Corporation
Collaborators
Medtronic - MITG
search

1. Study Identification

Unique Protocol Identification Number
NCT00444067
Brief Title
Study to Evaluate Safety & Effectiveness of Spinal Sealant
Official Title
A Prospective, Multi-Center, Randomized Controlled Study to Compare the Spinal Sealant System as an Adjunct to Sutured Dural Repair With Standard of Care Methods During Spinal Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
September 2014
Overall Recruitment Status
Completed
Study Start Date
May 2007 (undefined)
Primary Completion Date
August 2009 (Actual)
Study Completion Date
August 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Integra LifeSciences Corporation
Collaborators
Medtronic - MITG

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To evaluate a spinal sealant as an adjunct to sutured dural repair compared to standard of care techniques.
Detailed Description
Neurosurgical procedures in the spine often involve incision of the dura mater to access the spinal cord. If the dural incision is not properly repaired and watertight closure is not achieved cerebrospinal fluid (CSF) can escape presenting a risk for significant morbidity. The most frequent complication of CSF leak is recurring headache complicated with symptoms of nausea and vomiting. Furthermore fluid collection under skin prevents proper wound healing and may lead to wound breakdown and infection of the incision or both. Persistent CSF leak has also been associated with the development of cerebellar hemorrhage and subdural hematoma. Primary repair and watertight closure are paramount to minimizing risk and sequelae associated with CSF leak.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cerebrospinal Fluid Leakage, Subdural
Keywords
Prevention of CSF leak

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
98 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Spinal Sealant System
Arm Type
Experimental
Arm Description
Spinal Sealant System
Arm Title
Standard of Care
Arm Type
Active Comparator
Arm Description
Standard of care methods as an adjunct to sutured dural repair
Intervention Type
Device
Intervention Name(s)
Spinal Sealant
Intervention Description
Spinal Sealant System
Intervention Type
Other
Intervention Name(s)
Standard of Care
Intervention Description
Standard of Care
Primary Outcome Measure Information:
Title
Percent(%) Success in Obtaining a Watertight Closure Following Assigned Treatment (Spinal Sealant or Control)
Description
Percent(%) success in obtaining a watertight closure following assigned treatment (Spinal Sealant or Control) where success is defined as: A watertight closure of the dural repair intraoperatively after study treatment, confirmed by Valsalva maneuver at 20-25 cm H2O for 5-10 seconds.
Time Frame
Intra-operative
Other Pre-specified Outcome Measures:
Title
Incidence of Post-Operative CSF Leaks
Description
Percentage of participants with CSF leaks within 90 days post-operatively as determined from clinical diagnosis by one of the following methods: CSF leak or pseudomeningocele related surgical intervention (i.e., breaking skin) within 90 days post-procedure; or CSF leak confirmation by diagnostic testing within 90 days post-procedure; or CSF leak confirmation by clinical evaluation within 90 days post-procedure
Time Frame
90 Days
Title
Incidence of Post-Operative Surgical Site Infections (SSIs)
Description
•Percentage of participants who incur an SSI within 90 days post-procedure determined by clinical diagnosis SSIs were diagnosed and classified in accordance with the Centers for Disease Control (CDC) criteria for evaluation and diagnosis of nosocomial surgical site infections and were classified as one of the following (Superficial, Deep or Organ/Space).
Time Frame
90 Days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects scheduled for a spinal procedure that requires a dural incision
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jen Doyle
Organizational Affiliation
Conlfuent Surgical/Covidien
Official's Role
Study Director
Facility Information:
Facility Name
Confluent Surgical, Inc.
City
Bedford
State/Province
Massachusetts
ZIP/Postal Code
01730
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
25646746
Citation
Wright NM, Park J, Tew JM, Kim KD, Shaffrey ME, Cheng J, Choudhri H, Krishnaney AA, Graham RS, Mendel E, Simmons N. Spinal sealant system provides better intraoperative watertight closure than standard of care during spinal surgery: a prospective, multicenter, randomized controlled study. Spine (Phila Pa 1976). 2015 Apr 15;40(8):505-13. doi: 10.1097/BRS.0000000000000810.
Results Reference
derived

Learn more about this trial

Study to Evaluate Safety & Effectiveness of Spinal Sealant

We'll reach out to this number within 24 hrs